StocksDeepDive
Snapshot · FTSE 100 · generated 2026-10-13 03:33 UTC

AZN.L — AstraZeneca PLC

FAIR (MOS +9.6%) · Quality 69/100

Price
119.98
Intrinsic value
132.73
Margin of safety
+9.6%
Implied growth (reverse DCF)
+6.2%
model assumes +8.0%
Value Score
48.1
Quality
69
Psychology
7.6
Discovery
105.1
price/volume attention only
Moat score
72.5
erosion: none

Value Score: top 32% of FTSE 100 · Quality: top 24%

Dividend: 2.39/share (TTM) · yield 2.0% · payout 47%

Open the interactive Deep Dive for AZN.L →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/AZN.L - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is AZN.L undervalued?

As of 2026-10-13, AZN.L trades at 119.98 against a computed intrinsic value of 132.73 (+9.6% margin of safety) - StocksDeepDive's valuation label for this is FAIR. This is a described calculation from public data, not a recommendation.

What is AstraZeneca PLC's Value Score?

AstraZeneca PLC's Value Score is 48.1 as of 2026-10-13 - it combines value, quality, crowd psychology and market attention into one number.

Does AZN.L pay a dividend?

Yes - AZN.L's trailing twelve-month dividend is 2.39/share, a yield of 2.0% at the current price (as of 2026-10-13).